Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series Read More > August 1, 2017
Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series Read More > August 1, 2017
Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy Read More > July 26, 2017
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro Read More > July 13, 2017
Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency? Read More > July 1, 2017
